NPI: 1902283740 · CHERAW, SC 29520 · Rural Acute Care Hospital · NPI assigned 04/30/2015
Authorized official ERVIN, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | ERVIN, SAMUEL (SR VICE PRESIDENT & CFO) |
| Parent Organization | MCLEOD HEALTH |
| NPI Enumeration Date | 04/30/2015 |
Other providers sharing the same authorized official: ERVIN, SAMUEL
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 47,392 | $847K |
| 2019 | 50,540 | $747K |
| 2020 | 44,586 | $639K |
| 2021 | 57,862 | $860K |
| 2022 | 62,152 | $1.11M |
| 2023 | 52,305 | $1.35M |
| 2024 | 46,581 | $1.22M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 36415 | Collection of venous blood by venipuncture | 28,589 | 22,420 | $1.74M |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 4,320 | 3,975 | $724K |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 17,119 | 15,943 | $567K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 8,223 | 2,199 | $357K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 3,567 | 3,415 | $350K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 2,716 | 2,557 | $325K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 3,196 | 3,001 | $256K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 5,153 | 4,104 | $188K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 9,016 | 7,778 | $170K |
| J7030 | Infusion, normal saline solution , 1000 cc | 1,736 | 1,421 | $148K |
| 81001 | 10,565 | 9,526 | $137K | |
| 99284 | Emergency department visit for the evaluation and management, high severity | 15,537 | 14,027 | $132K |
| 70450 | Computed tomography, head or brain; without contrast material | 4,395 | 3,968 | $120K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1,474 | 1,380 | $106K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2,073 | 1,875 | $106K |
| 71046 | Radiologic examination, chest; 2 views | 5,384 | 5,065 | $101K |
| J7120 | Ringers lactate infusion, up to 1000 cc | 1,408 | 1,171 | $88K |
| 81003 | 3,815 | 3,513 | $69K | |
| 81025 | 5,553 | 5,206 | $68K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 839 | 820 | $63K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 2,757 | 1,843 | $58K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1,087 | 1,049 | $55K |
| 73610 | 817 | 764 | $51K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 12,005 | 10,146 | $51K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 363 | 125 | $46K |
| 73630 | 991 | 918 | $46K | |
| 71045 | Radiologic examination, chest; single view | 7,289 | 6,382 | $38K |
| 80053 | Comprehensive metabolic panel | 12,999 | 10,802 | $36K |
| 96361 | Intravenous infusion, hydration; each additional hour | 4,607 | 3,725 | $33K |
| 73030 | 780 | 721 | $33K | |
| 73130 | 503 | 459 | $32K | |
| 36416 | 3,596 | 2,136 | $30K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2,047 | 1,820 | $28K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 11,121 | 9,221 | $26K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1,458 | 1,360 | $25K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 2,434 | 2,234 | $25K |
| 87070 | 381 | 368 | $23K | |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9,009 | 7,925 | $21K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 2,369 | 2,224 | $21K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 202 | 194 | $18K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 26 | 25 | $16K |
| 73110 | 229 | 214 | $14K | |
| 73564 | 302 | 261 | $13K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 1,124 | 1,095 | $13K |
| 73562 | 343 | 298 | $12K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 2,204 | 1,673 | $12K |
| 97161 | 456 | 435 | $11K | |
| 96375 | Therapeutic injection; each additional sequential IV push | 6,035 | 4,862 | $11K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 23,246 | 18,456 | $10K |
| 72100 | 301 | 292 | $10K | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 138 | 127 | $9K |
| 74018 | 193 | 179 | $8K | |
| 59025 | Fetal non-stress test | 172 | 119 | $8K |
| G0378 | Hospital observation service, per hour | 2,821 | 1,541 | $7K |
| 96376 | 2,159 | 1,372 | $7K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 3,104 | 2,883 | $7K |
| 82948 | 2,208 | 869 | $7K | |
| 82803 | 742 | 633 | $6K | |
| 87040 | 3,648 | 2,032 | $6K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 362 | 355 | $5K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1,372 | 1,294 | $5K |
| 87077 | 628 | 578 | $5K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 860 | 795 | $4K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 28 | 27 | $4K |
| 73502 | 171 | 153 | $4K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 5,467 | 4,712 | $3K |
| J7050 | Infusion, normal saline solution, 250 cc | 827 | 526 | $2K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 2,449 | 2,104 | $2K |
| 71250 | 28 | 26 | $2K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 26 | 26 | $2K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 464 | 444 | $2K |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 37 | 34 | $2K |
| J2270 | Injection, morphine sulfate, up to 10 mg | 2,345 | 1,929 | $2K |
| 87807 | 134 | 130 | $2K | |
| 87430 | 361 | 349 | $2K | |
| 97162 | 104 | 102 | $2K | |
| 92523 | 12 | 12 | $2K | |
| 73080 | 30 | 27 | $2K | |
| 87210 | 83 | 77 | $1K | |
| 76830 | Ultrasound, transvaginal | 14 | 14 | $1K |
| 84145 | 2,639 | 2,192 | $1K | |
| J2704 | Injection, propofol, 10 mg | 1,413 | 1,333 | $1K |
| 97535 | Self-care/home management training, each 15 minutes | 18 | 12 | $1K |
| 84702 | 835 | 751 | $1K | |
| 86850 | 497 | 434 | $1K | |
| 36600 | 375 | 335 | $996.74 | |
| 80076 | 1,939 | 1,822 | $828.49 | |
| 80061 | Lipid panel | 1,106 | 1,064 | $799.75 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 2,439 | 2,309 | $716.24 |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 21 | 13 | $701.22 |
| 83880 | 2,836 | 2,532 | $672.61 | |
| 84484 | 8,904 | 6,387 | $615.51 | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1,135 | 1,106 | $522.97 |
| 76641 | 16 | 16 | $519.40 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 3,974 | 3,651 | $504.13 |
| 74022 | 65 | 64 | $464.56 | |
| 86900 | 807 | 727 | $437.77 | |
| J1170 | Injection, hydromorphone, up to 4 mg | 595 | 455 | $359.15 |
| 84443 | Thyroid stimulating hormone (TSH) | 3,098 | 2,893 | $259.70 |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 137 | 50 | $229.50 |
| A9270 | Non-covered item or service | 2,234 | 1,331 | $201.46 |
| 84439 | 876 | 846 | $184.37 | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 174 | 78 | $151.57 |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 1,221 | 1,141 | $100.00 |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 533 | 488 | $95.35 |
| 82550 | 290 | 250 | $75.31 | |
| 85610 | 3,788 | 3,355 | $73.86 | |
| 83735 | 9,479 | 7,487 | $66.23 | |
| 86140 | 250 | 211 | $33.72 | |
| 71275 | Computed tomographic angiography, chest, with contrast material | 925 | 879 | $32.82 |
| 80179 | 398 | 361 | $24.04 | |
| 80143 | 431 | 384 | $24.04 | |
| 80069 | 16 | 13 | $22.40 | |
| 83655 | 138 | 133 | $21.71 | |
| 82077 | 907 | 803 | $20.60 | |
| 83690 | 6,097 | 5,362 | $20.00 | |
| 85027 | 2,314 | 2,137 | $18.50 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 1,251 | 1,210 | $15.31 |
| 86738 | 186 | 179 | $13.24 | |
| 85730 | 3,170 | 2,857 | $9.19 | |
| J2060 | Injection, lorazepam, 2 mg | 185 | 143 | $7.69 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 691 | 597 | $4.09 |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | 196 | 162 | $4.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 929 | 772 | $0.23 |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 430 | 344 | $0.00 |
| 83605 | 4,161 | 3,310 | $0.00 | |
| 87205 | 67 | 39 | $0.00 | |
| 86901 | 808 | 728 | $0.00 | |
| 85379 | 630 | 599 | $0.00 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 1,121 | 1,032 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 596 | 532 | $0.00 |
| J3490 | Unclassified drugs | 1,315 | 1,147 | $0.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 75 | 68 | $0.00 |
| 85651 | 60 | 52 | $0.00 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 1,151 | 1,074 | $0.00 |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 245 | 224 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 19 | 17 | $0.00 |
| 84703 | 174 | 164 | $0.00 | |
| 70498 | 17 | 14 | $0.00 | |
| 70496 | 17 | 14 | $0.00 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 125 | 121 | $0.00 |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 27 | 26 | $0.00 |
| 94760 | 137 | 82 | $0.00 | |
| 80320 | 140 | 130 | $0.00 | |
| 97165 | 46 | 41 | $0.00 | |
| J1940 | Injection, furosemide, up to 20 mg | 60 | 40 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 40 | 38 | $0.00 |
| 87147 | 33 | 30 | $0.00 | |
| 80329 | 16 | 16 | $0.00 | |
| J8540 | Dexamethasone, oral, 0.25 mg | 34 | 33 | $0.00 |
| 87081 | 14 | 13 | $0.00 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | 608 | 522 | $0.00 |
| 87186 | 943 | 844 | $0.00 | |
| J3370 | Injection, vancomycin hcl, 500 mg | 68 | 50 | $0.00 |
| 90715 | 99 | 96 | $0.00 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 110 | 102 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 231 | 192 | $0.00 |
| J3475 | Injection, magnesium sulfate, per 500 mg | 159 | 131 | $0.00 |
| 84100 | 557 | 477 | $0.00 | |
| 83525 | 270 | 267 | $0.00 | |
| 82565 | 42 | 40 | $0.00 | |
| J7510 | Prednisolone oral, per 5 mg | 110 | 101 | $0.00 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 118 | 67 | $0.00 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 170 | 164 | $0.00 |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 54 | 28 | $0.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 31 | 26 | $0.00 |
| J0692 | Injection, cefepime hydrochloride, 500 mg | 16 | 12 | $0.00 |